You have 9 free searches left this month | for more free features.

Unclassified Renal Cell Carcinoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma

Recruiting
  • Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 2, 2022

Clear Cell Papillary Renal Tumor, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma Trial in Los

Recruiting
  • Clear Cell Papillary Renal Neoplasm
  • +10 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 25, 2021

Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 24, 2023

Delving Into Participation Trends in Renal Cell Carcinoma

Not yet recruiting
  • Renal Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Recruiting
    • Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jun 5, 2023

    Moesin Expression in Clear Cell Renal Cell Carcinoma

    Completed
    • Renal Cell Carcinoma
    • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
    • (no location specified)
    Sep 20, 2023

    Renal Cell Carcinoma Trial (Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 11, 2023

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

    Not yet recruiting
    • ccRCC
    • +20 more
    • (no location specified)
    Jul 6, 2023

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Metastatic Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

    Available
    • Clear Cell Renal Cell Carcinoma
    • 89Zr-DFO-girentuximab
    • Los Angeles, California
      UCLA
    Oct 12, 2023

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 28, 2023

    Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

    Recruiting
    • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
    • AK104(anti-PD-1/CTLA-4 bi-specific antibody ,intravenously),lenvatinib( targeted VEGFR 1-3、FGFR、PDGFRα, small molecule TKI,orally
    • Shanghai, Shanghai, China
      Shanghai Renji Hospital
    Sep 12, 2023

    Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • +2 more
    • (no location specified)
    May 14, 2023

    Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

    Recruiting
    • Advanced Renal Cell Carcinoma
    • ST-1898 tablets
    • Beijing, Beijing, China
      Peking University Cancer Hospital & Institute
    Nov 6, 2023

    Renal Cell Carcinoma Trial (HS-10516)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 24, 2023

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

    Not yet recruiting
    • Renal Cell Carcinoma
    • +2 more
    • Implantable Microdevice (IMD)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 17, 2023

    Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pembrolizumab injection
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 20, 2023

    Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Sodium Pentaborate
    • Tabriz, East Azarbayejan, Iran, Islamic Republic of
      Imam Reza hospital and Clinic of Salamat
    Mar 23, 2023

    Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

    Not yet recruiting
    • Papillary Renal Cell Carcinoma
    • (no location specified)
    Nov 24, 2023

    Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pucotenlimab Combined With Lenvatinib
    • Guangzhou, Other (Non U.s.), China
      Sun Yat-sen University Cancer Center
    Nov 10, 2023

    Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

    Not yet recruiting
    • Advanced Clear Cell Renal Carcinoma (Ccrcc)
    • Papillary Renal Cell Carcinoma (Prcc)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Renal Cell Carcinoma, First-line Treatment, Non Clear Cell Renal Cell Carcinoma Trial in Chengdu (AK104, Axitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • +3 more
    • Chengdu, Sichuan, China
      West China Hospital
    Apr 10, 2023

    Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1

    Recruiting
    • Carcinoma, Renal Cell
    • Kidney Neoplasms
      • Yiwu, Zhejiang, China
        The Fourth Affiliated Hospital Zhejiang University School of Med
      Mar 27, 2023

      Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma

      Completed
      • Carcinoma, Renal Cell
      • We do not have any interventions. This study is based on obseravation.
      • (no location specified)
      Oct 27, 2023